Axiomyx Product Licence Matrix
Document version: 1.1 Effective date: 2026-08-26 Last updated: 2026-08-26
1. Commercial matrix
| Term | Personal | Business | Enterprise |
|---|---|---|---|
| Customer | One person | One legal entity | Defined in negotiated order |
| Plans | Personal Free and Axiomyx Premium | Business | Defined in negotiated order |
| Free allowance | 500 MB of Active Evidence | Not offered | Negotiated |
| Annual price | Not offered | NZ$1,490/year | Talk to us |
| Monthly price | Free at US$0; Premium at US$9.99/month per product | NZ$159/month | Custom |
| Trial | Personal Free is not a trial; Premium trial only if the relevant store listing offers one | 30 days when offered at checkout | Evaluation arranged directly |
| Payment at trial start | Relevant store terms apply | No subscription charge; payment method required | Negotiated |
| Post-trial billing | Relevant store terms apply | Selected annual or monthly cycle automatically starts unless cancelled | Negotiated |
| Paid users | One person | Up to ten Authorised Users | Custom |
| Paid installations or Deployments | Relevant store account and device terms for that product | One production and one non-production Deployment | Custom |
| Trial scope | Personal Free has no trial expiry; any Premium trial follows the relevant store offer | One evaluation Deployment; up to three evaluation users only if final configuration confirms it | Negotiated |
| Data custody | Customer-controlled | Customer-controlled | Customer-controlled unless written order says otherwise |
| Support | Personal support | Business support | Negotiated support/SLA |
| Updates | Compatible Free and Premium releases through the relevant store | While subscription is active | Negotiated |
| Offline licensing | Not included | Not included | May be negotiated |
| Self-service checkout | Apple App Store or Microsoft Store | Axiomyx Lemon Squeezy storefront | No |
Personal Free does not require a paid subscription. Each Personal product requires its own Premium store subscription to remove that product's Axiomyx Active Evidence quota. A Premium subscription does not unlock another Personal product or platform product. Monthly and annual Business subscriptions provide the same operational rights. Annual is a billing option, not a broader licence.
Personal is priced in US dollars. Local currency conversion, taxes and store terms may apply. Business is priced in New Zealand dollars. Future purchase and renewal pricing may change after appropriate notice.
2. Deployment requirements
| Requirement | Personal | Business | Enterprise |
|---|---|---|---|
| Packaging | Native Apple or Microsoft store application | Docker/OCI artefacts and Documentation | Negotiated artefacts and Documentation |
| Database | Embedded SQLite | Customer-managed PostgreSQL | Negotiated/customer-managed |
| Authentication | Relevant platform-store installation and Free or Premium plan status | OIDC with HTTPS issuer validation | Negotiated |
| Production use | Within Personal licence and validated environment | One production Deployment | Negotiated |
| Non-production use | Relevant store account and device terms | One non-production Deployment | Negotiated |
| Native installer | Store-delivered native application | Not promised | Not promised unless ordered |
| Backups | Customer responsibility | Customer responsibility | Customer responsibility unless ordered otherwise |
3. Personal plan-state matrix
Active Evidence is the combined source-file size of supported files that Personal has accepted and retained as evidence. Personal Free permits up to 500,000,000 bytes (500 MB) of Active Evidence. Premium removes that Axiomyx product quota while it is active; device storage, operating-system, hardware, model, provider, and context-window limits still apply.
| Operation | Personal Free | Active Premium | Premium ended or cancelled |
|---|---|---|---|
| Inspect, search, retrieve, export, or delete retained local evidence | Allowed | Allowed | Allowed |
| New ingestion and background folder growth | Allowed while Active Evidence remains within 500 MB | No Axiomyx Active Evidence quota | Allowed while Active Evidence remains within 500 MB |
| Canonicalisation, signatures, indexing, provenance, and AI-context operations | Allowed within the plan's evidence allowance | Allowed without an Axiomyx evidence quota | Allowed on retained evidence; new evidence remains subject to 500 MB |
| Choose or remove source files and folders | Allowed | Allowed | Allowed |
| Future compatible releases and security updates | Through the relevant store | Through the relevant store while Premium is active | Free-compatible releases through the relevant store |
| Support | Best-efforts | Best-efforts | Best-efforts |
Ending Premium returns the product to Personal Free. It does not delete original source files or retained local evidence. If retained Active Evidence exceeds 500 MB, further additions or folder growth can be restricted until the Customer removes enough evidence or restores Premium.
4. Business entitlement-state matrix
The table below applies to Business entitlements.
| Operation | Active trial | Trial expired without conversion | Active paid subscription | Paid period ended after valid payment |
|---|---|---|---|---|
| Inspect retained local data | Allowed | Allowed | Allowed | Allowed |
| Export retained local data | Allowed | Allowed | Allowed | Allowed |
| Delete retained local data | Allowed | Allowed | Allowed | Allowed |
| Back up retained local data | Allowed | Allowed | Allowed | Allowed |
| Activate a valid entitlement | Allowed | Allowed | Allowed | Support may be required for fresh reactivation |
| Produce sanitised diagnostics | Allowed | Allowed | Allowed | Allowed |
| New ingestion/canonicalisation | Within trial scope | Denied | Within paid scope | Last fully paid release may continue within scope |
| New signatures/indexing/provenance | Within trial scope | Denied | Within paid scope | Last fully paid release may continue within scope |
| AI-context operations | Within trial scope | Denied | Within paid scope | Last fully paid release may continue within scope |
| Add users or Deployments | Within trial scope | Denied | Within tier limits | No additional installations or Deployments |
| Future releases and security updates | Trial release only | Denied | Included while active | Denied |
| Support | Evaluation support as offered | Activation/data-access issues only as required | Included by tier | Not included, except rights/remedy and reactivation handling |
Trial expiry, cancellation, non-renewal, or activation denial does not delete, encrypt, seize, transfer, or place retained Customer Data in Axiomyx custody.
5. Support matrix
| Support item | Personal | Business | Enterprise |
|---|---|---|---|
| Email support | Best-efforts | Best-efforts | Negotiated |
| Installation and activation | Store installation and entitlement assistance | Yes | Negotiated |
| Deployment configuration | Supported Apple or Microsoft store release | PostgreSQL, OIDC, HTTPS issuer guidance | Negotiated |
| Defect triage | Best-efforts | Best-efforts | Negotiated targets |
| Security notices | Appropriate customer or store channel | Appropriate customer channel | Negotiated |
| Managed operations | No | No | Only if expressly ordered |
Personal updates are delivered through the relevant platform store. Business supported-release requirements are stated in the applicable release documentation.
Effective date: 2026-08-26
Questions about this document: av@axiomyx.tech